| Name | Title | Contact Details |
|---|---|---|
Kellen Zollinger |
Director of Financial Planning and Analysis | Profile |
Colleen Franke |
Human Resources Director | Profile |
Sean Miller |
Chief Commercial Officer | Profile |
Pat McCarty |
Chief Financial Officer | Profile |
Nava Health is a vertically integrated, tech-enabled healthcare practice that combines integrative, functional, preventive, and regenerative medicine to optimize health and increase longevity.
Formed by revenue cycle industry leaders, Currance is a Rev-Cycle Performance solutions company focused on empowering community providers, physician practices and healthcare systems to achieve and sustain yield performance improvement. Currance`s strategy of Performance Partnering supports your own team by offering everything needed to drive yield performance: an intelligent technology platform that integrates with existing systems, tailored solutions, and professional services for operationalizing the technology and sustaining exceptional results. The Currance approach encompasses best-in-class knowledge of revenue cycle management, proprietary technologies, and the proven ability to engage, train, and mentor employees, adding value to clients` organizations. We embrace a mindset rooted in science and operational experience, enabling highly efficient processes and precise workflow design that improve profitability and help build patient-centered, high-performing organizations.
Keller Medical Communications is a Newburyport, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Kensington Retirement Comnty is a Alhambra, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
With operation centers in the United States and the United Kingdom and an R&D center of excellence in Finland, CRF Health is committed to driving the global change to higher-quality outcomes and more efficient paper-free clinical trials through improved patient engagement via intuitive and patient-focused eCOA (electronic Clinical Outcome Assessment) technology. By improving the process of conducting clinical studies, we help companies bring new medicines to market quickly, safely and more cost-effectively.